Search research articles
Contact Us
Filters
Showing results (1-10 of 351) with videos related to
Page
of 36
Sort By:
The New England Journal of Medicine
|
June 1, 2026
Precision Intensification in Metastatic Prostate Cancer
Rana R McKay
The New England Journal of Medicine
|
August 18, 2021
The Promise of Adjuvant Immunotherapy in Renal-Cell Carcinoma
Rana R McKay
European Urology Open Science
|
October 4, 2022
Treatment Intensification for Low-risk Metastatic Hormone-sensitive Prostate Cancer: The Time Is Now
Rana R McKay
Oncology (Williston Park, N.Y.)
|
February 19, 2013
Prostate cancer 2012: where do we stand and where are we heading?
Rana R McKay, Philip Kantoff
Annals of Translational Medicine
|
February 5, 2020
Immunotherapy combinations transform the treatment paradigm for advanced renal cell carcinoma
Justin A Shaya, Rana R McKay
Current Opinion in Urology
|
June 4, 2019
Clinical implications of genetic aberrations in metastatic prostate cancer
Zachery R Reichert, Rana R McKay
International Journal of Radiation Oncology, Biology, Physics
|
February 5, 2025
When Local Therapy Is the Answer for Metastatic Cancer
Tyler M Seibert, Rana R McKay
European Urology Focus
|
April 25, 2025
Mitigating the Risk of Skeletal Events in Metastatic Renal Cell Carcinoma
Yu-Wei Chen, Rana R McKay
European Urology Oncology
|
January 23, 2021
Streamlining Germline Genetic Testing in Prostate Cancer
Rana R McKay, Emmanuel S Antonarakis
European Urology
|
December 14, 2024
Clinical Implementation of Minimal Residual Disease Testing in Genitourinary Cancers: Bridging Promise and Practice
Rana R McKay, Joshua Lang, Himisha Beltran
Page
of 36
Search research articles
Search
Showing results (1-10 of 351) with videos related to
Sort By:
Page
of 36
The New England Journal of Medicine
|
June 1, 2026
Precision Intensification in Metastatic Prostate Cancer
Rana R McKay
The New England Journal of Medicine
|
August 18, 2021
The Promise of Adjuvant Immunotherapy in Renal-Cell Carcinoma
Rana R McKay
European Urology Open Science
|
October 4, 2022
Treatment Intensification for Low-risk Metastatic Hormone-sensitive Prostate Cancer: The Time Is Now
Rana R McKay
Oncology (Williston Park, N.Y.)
|
February 19, 2013
Prostate cancer 2012: where do we stand and where are we heading?
Rana R McKay, Philip Kantoff
Annals of Translational Medicine
|
February 5, 2020
Immunotherapy combinations transform the treatment paradigm for advanced renal cell carcinoma
Justin A Shaya, Rana R McKay
Current Opinion in Urology
|
June 4, 2019
Clinical implications of genetic aberrations in metastatic prostate cancer
Zachery R Reichert, Rana R McKay
International Journal of Radiation Oncology, Biology, Physics
|
February 5, 2025
When Local Therapy Is the Answer for Metastatic Cancer
Tyler M Seibert, Rana R McKay
European Urology Focus
|
April 25, 2025
Mitigating the Risk of Skeletal Events in Metastatic Renal Cell Carcinoma
Yu-Wei Chen, Rana R McKay
European Urology Oncology
|
January 23, 2021
Streamlining Germline Genetic Testing in Prostate Cancer
Rana R McKay, Emmanuel S Antonarakis
European Urology
|
December 14, 2024
Clinical Implementation of Minimal Residual Disease Testing in Genitourinary Cancers: Bridging Promise and Practice
Rana R McKay, Joshua Lang, Himisha Beltran
Page
of 36